Long-acting therapeutics

Off-patent liver disease drug could prevent COVID-19 infection

December 5, 2022

Becoming an Expert: Studying how long-acting drug delivery formulations interact with the human immune system

July 26, 2022

Exchanging knowledge at the edge of pharmacology and materials chemistry

March 24, 2022

World AIDS Day: Are long-acting HIV therapies the future?

December 1, 2021

AGILE COVID-19 drug testing platform opens new trial in South Africa

October 7, 2021

Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C

September 21, 2021

New Unilever Radiochemistry Research Fellow

May 25, 2021

The Nanotherapeutics Hub joins iiCON

May 18, 2021

Long-acting injectable medicine as potential route to COVID-19 therapy

April 14, 2021

Two new therapies to be tested in ground-breaking COVID-19 clinical trial

January 12, 2021